|
Incorporated as a private limited company in Maharashtra in May '87 Bacil Pharma (BPL) was converted into a public limited company in Oct.'90. BPL came out with a public issue of Rs 7 cr in Mar.'94 to set up a plant at Vapi to manufacture bulk drugs like atenalol norfloxacin pefloxacin and ciprofloxacin. The comapany entered into a marketing arrangement with a distributor Kam Han Industries Hong Kong to export 50% of the production. Due to various reasons the civil works at Vapi were affected. However to avoid further delay in project implementation the company acquired from SICOM an existing bulk drug unit with necessary infrastructure and production facilities at Lote Parashuram (near Ratnagiri). |
Bacil Pharma Ltd.
| BSE: 524516 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE711D01018 |
| BSE 00:00 | 14 Jun | 7.35 |
0 (0.00%) |
OPEN
7.35 |
HIGH
7.35 |
LOW
7.35 |
| NSE 05:30 | 01 Jan | Bacil Pharma Ltd |
| OPEN | 7.35 |
| PREVIOUS CLOSE | 7.35 |
| VOLUME | 7 |
| 52-Week high | 7.80 |
| 52-Week low | 2.22 |
| P/E | |
| Mkt Cap.(Rs cr) | 4 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Bacil Pharma Ltd. (BACILPHARMA) - Company History
Quick Links for Bacil Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
